Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01758549 · ClinicalTrials.gov registry record · NA
Randomized Trial of Aggressive Fluid Hydration to Prevent Post ERCP Pancreatitis
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT01758549 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 62 participants.
The verdict
NCT01758549, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
1. ERCP is a commonly performed endoscopic procedure used to treat stones and blockages of the bile duct as well as to manage leaks which occurs following laparoscopic gallbladder removal. 2. Post ERCP pancreatitis (PEP) complicates 5-15% of biliary endoscopic procedures and results in considerable suffering and cost. 3. Patients with acute pancreatitis are treated with fluids. 4. Our aim is to assess whether prophylactic treatment with aggressive intravenous hydration prevents ERCP pancreatitis. 5. In a blinded fashion patients will be randomized to aggressive intravenous versus moderate hydration during and aftere ERCP for standard clinical indications. Our hypothesis is that prophylactic treatment with aggressive intravenous hydration protects against ERCP pancreatitis.
Interventions
- OTHER Aggressive Intravenous Hydration Group
- OTHER Standard Fluids Arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01758549
The ClinicalTrials.gov registry entry for NCT01758549 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aggressive Intravenous Hydration Group is the first listed.
NCT01758549 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01758549 about?
NCT01758549 is a clinical study titled "Randomized Trial of Aggressive Fluid Hydration to Prevent Post ERCP Pancreatitis". 1. ERCP is a commonly performed endoscopic procedure used to treat stones and blockages of the bile duct as well as to manage leaks which occurs following laparoscopic gallbladder removal. 2. Post ERCP pancreatitis (PEP) complicates 5-15% of biliary endoscopic procedures and results in considerable ...
What is the current status of trial NCT01758549?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2012-07. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01758549?
The interventions under investigation include: Aggressive Intravenous Hydration Group (OTHER), Standard Fluids Arm (OTHER).
Who is sponsoring clinical trial NCT01758549?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.